Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
11.15
+0.33 (3.05%)
Jun 2, 2025, 11:02 AM - Market open
Niagen Bioscience Stock Forecast
Stock Price Forecast
According to 2 professional analysts, the 12-month price target for Niagen Bioscience stock ranges from a low of $11 to a high of $13. The average analyst price target of $12 forecasts a 7.62% increase in the stock price over the next year.
Price Target: $12.00 (+7.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '25 | May '25 |
---|---|---|
Strong Buy | 1 | 2 |
Buy | 0 | 0 |
Hold | 0 | 0 |
Sell | 0 | 0 |
Strong Sell | 0 | 0 |
Total | 1 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +16.59% | May 27, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -1.35% | Apr 8, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -1.35% | Mar 31, 2025 |
Financial Forecast
Revenue This Year
124.95M
from 99.60M
Increased by 25.46%
Revenue Next Year
152.09M
from 124.95M
Increased by 21.72%
EPS This Year
0.13
from 0.11
Increased by 14.36%
EPS Next Year
0.22
from 0.13
Increased by 72.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 129.9M | 159.7M | 189.7M |
Avg | 125.0M | 152.1M | 180.9M |
Low | 119.3M | 142.9M | 170.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 30.4% | 27.8% | 24.8% |
Avg | 25.5% | 21.7% | 19.0% |
Low | 19.8% | 14.4% | 12.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.20 | 0.28 | 0.41 |
Avg | 0.13 | 0.22 | 0.37 |
Low | 0.08 | 0.17 | 0.33 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 81.4% | 125.4% | 88.2% |
Avg | 14.4% | 73.0% | 71.1% |
Low | -28.7% | 32.4% | 53.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.